AI: Page 5


  • A head shot of Martin Stumpe, Danaher's chief data and artificial intelligence officer.
    Image attribution tooltip
    Permission granted by Danaher
    Image attribution tooltip

    Danaher names Martin Stumpe as chief data and AI officer

    Martin Stumpe will take over the new position after previously working as Tempus’ chief of AI and the head of Google’s pathology team.

    By June 6, 2024
  • Professional photo of Marcus Schabacker in an office space.
    Image attribution tooltip
    Permission granted by ECRI
    Image attribution tooltip
    Q&A

    Stronger oversight of AI needed in medical devices, ECRI CEO says

    Marcus Schabacker called for more upfront regulations and postmarket monitoring to better understand how AI features affect patient care.

    By June 5, 2024
  • Front sign of FDA building Explore the Trendline
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    AI tools are transforming the medtech space

    As artificial intelligence becomes more prominent in the medtech sector, the technology is changing what it means to be a medical device — and attracting top companies.

    By MedTech Dive staff
  • A watch that says parky next to a smartphone, with another watch on the right.
    Image attribution tooltip
    Courtesy of H2O Therapeutics
    Image attribution tooltip

    FDA seeks AI tech to predict, detect Parkinson’s symptoms

    By testing artificial intelligence and machine learning models, the agency hopes to come up with best practices for Parkinson’s measures from wearables and smartphones.

    By May 21, 2024
  • A union jack flag waves in the wind
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    UK sets out position on regulating AI as a medical device

    Some AI products that currently can be put on the market without conformity assessment will move to a higher risk class, requiring more scrutiny.

    By May 3, 2024
  • Quest Diagnostics building
    Image attribution tooltip
    Courtesy of Quest Diagnostics
    Image attribution tooltip

    Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab

    PathAI is selling its diagnostics assets, including a Tennessee laboratory, but will continue to support its biopharmaceutical customers.

    By May 2, 2024